PDF) P-136 Revised International Prognostic Scoring System (IPSS-R), stratification for myelodysplastic syndrome (MDS) patients under hypomethylating treatment | M. Iastrebner - Academia.edu
Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group - ScienceDirect
Online MDS IPSS Calculator - HemUpdates.com
MDS IPSS-R Calculator by Markations
The IPSS-Molecular, a new risk stratification for patients with MDS
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register - Moreno Berggren - 2018 - British Journal of Haematology - Wiley Online Library
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes | NEJM Evidence
MDS Foundation, Inc. - Do You Know Your MDS Subtype and IPSS-R Score? Our recent survey shows that only 50% of patients know their subtype and only about 30% know their IPSS-R
MDS IPSS-R Calculator - Advanced by Markations
Galen eCalcs - Calculator: IPSS - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki
MDS IPSS-R Calculator Basic APK for Android Download
MDS IPSS-R Calculator by Markations
Myelodysplastic Syndromes: Molecular & Clinical Classifications
https://www.lls.org/myelodysplastic-syndromes/diagnosis/international-prognostic- scoring-system
MDS IPSS-R Calculator by Markations
MDS IPSS-R Calculator Advanced - Apps on Google Play
IPSS-R Classification of MDS | Download Table
IPSS-R Calculator App | MDS Foundation
MDS — HaemBase
IPSS-R Classification system for myelodysplastic syndromes | Download Table
MDS IPSS-R Calculator Advanced APK for Android Download
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes | NEJM Evidence
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register - Moreno Berggren - 2018 - British Journal of Haematology - Wiley Online Library
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes | NEJM Evidence
